» Articles » PMID: 16803889

Structural Variations in the Catalytic and Ubiquitin-associated Domains of Microtubule-associated Protein/microtubule Affinity Regulating Kinase (MARK) 1 and MARK2

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Jun 29
PMID 16803889
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The microtubule-associated protein (MAP)/microtubule affinity regulating kinase (MARK)/Par-1 phosphorylates microtubule-associated proteins tau, MAP2, and MAP4 and is involved in the regulation of microtubule-based transport. Par-1, a homologue of MARK in Drosophila and Caenorhabditis elegans, is essential for the development of embryonic polarity. Four isoforms of MARK are found in humans. Recently, we reported the crystal structure of the catalytic and ubiquitin-associated domains of MARK2, an isoform enriched in brain (Panneerselvam, S., Marx, A., Mandelkow, E.-M., and Mandelkow, E. (2006) Structure 14, 173-183). It showed that the ubiquitin-associated domain (UBA) domain has an unusual fold and binds to the N-terminal lobe of the catalytic domain. This is at variance with a previous low resolution structure derived from small angle solution scattering (Jaleel, M., Villa, F., Deak, M., Toth, R., Prescott, A. R., Van Aalten, D. M., and Alessi, D. R. (2006) Biochem. J. 394, 545-555), which predicts binding of the UBA domain to the larger, C-terminal lobe. Here we report the crystal structure of the catalytic and UBA domain of another isoform, MARK1. Although the crystal packing of the two isoforms are unrelated, the overall conformations of the molecules are similar. Notably, the UBA domain has the same unusual conformation as in MARK2, and it binds at the same site. Remarkable differences occur in the catalytic domain at helix C, the catalytic loop, and the activation segment.

Citing Articles

Redox Regulation of Brain Selective Kinases BRSK1/2: Implications for Dynamic Control of the Eukaryotic AMPK family through Cys-based mechanisms.

Bendzunas G, Byrne D, Shrestha S, Daly L, Oswald S, Katiyar S bioRxiv. 2024; .

PMID: 38586025 PMC: 10996518. DOI: 10.1101/2023.10.05.561145.


Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.

Temal-Laib T, Peixoto C, Desroy N, De Lemos E, Bonnaterre F, Bienvenu N J Med Chem. 2023; 67(1):380-401.

PMID: 38147525 PMC: 10788895. DOI: 10.1021/acs.jmedchem.3c01428.


Computational analysis of regulatory regions in human protein kinases.

Pei J, Cong Q Protein Sci. 2023; 32(10):e4764.

PMID: 37632170 PMC: 10503413. DOI: 10.1002/pro.4764.


Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods.

Shi M, Zhou Y, Wei H, Zhang X, Du M, Zhou Y Front Pharmacol. 2023; 14:1116098.

PMID: 37124223 PMC: 10133576. DOI: 10.3389/fphar.2023.1116098.


In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2.

Chakraborty R, Bhattacharje G, Baral J, Manna B, Mullick J, Mathapati B Comput Biol Med. 2022; 147:105788.

PMID: 35809412 PMC: 9245396. DOI: 10.1016/j.compbiomed.2022.105788.